Okay, let's tackle this question about the chromosome associated with Renal Cell Carcinoma (RCC). First, I need to recall the different types of RCC and their genetic associations. The main types are clear cell, papillary, and chromophobe, each with different chromosomal abnormalities.

Clear cell RCC is the most common type. I remember that it's linked to mutations in the VHL gene, which is located on chromosome 3. The VHL gene is a tumor suppressor, so when it's lost or mutated, it leads to the uncontrolled growth of cells. The specific chromosomal location is 3p, right? So the loss of heterozygosity on 3p is a hallmark here.

Papillary RCC is different; it's associated with MET gene mutations on chromosome 7. Chromophobe RCC involves abnormalities in chromosomes 1, 2, 6, 11, 14, and 19, but the most characteristic is loss of 1p and 14q. So if the question is about the most common type, it's clear cell with 3p.

Looking at the options, if the correct answer is option C, then the options might be listed as A. 3q, B. 7p, C. 3p, D. 14q. So the correct answer is C. 3p. The other options are either related to other types of RCC or different cancers. For example, 3q might be a distractor for other cancers, and 7p might be related to other conditions. The key here is knowing that VHL on 3p is the main player in clear cell RCC.

**Core Concept**
Renal cell carcinoma (RCC) subtypes are associated with specific chromosomal abnormalities. Clear cell RCC, the most common subtype, is characterized by loss of chromosome 3p due to mutations in the **VHL tumor suppressor gene** (chromosome 3p25). This leads to dysregulation of hypoxia-inducible factors (HIFs) and uncontrolled angiogenesis.

**Why the Correct Answer is Right**
The correct answer corresponds to **chromosome 3p**. VHL gene mutations on 3p are central to clear cell RCC pathogenesis. VHL normally ubiquitinates HIF-α subunits for proteasomal degradation. Loss of VHL results in HIF stabilization, upregulating vascular endothelial growth factor (VEGF) and erythropoietin, driving tumor angiogenesis. This chromosomal loss is a diagnostic hallmark.

**Why Each Wrong Option is Incorrect**
**Option A:** Chromosome 3q is linked to other cancers (e.g., bladder cancer) but not RCC.
**Option B:** Chromosome 7p is associated with papillary RCC via MET gene activation, not 3p.
**Option D:** Chromosome 14q loss is seen in chromophobe RCC, not the most common subtype.

**Clinical Pearl / High-Yield Fact**
**"3p loss = clear cell RCC"** is a high-yield exam fact. Remember: VHL (3p) → HIF stabilization → VEGF overexpression → angiogenesis. Contrast with papillary RCC (7p MET mutations) and chromophobe RCC (

✓ Correct Answer: A. 3